Geneos Wealth Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1K Buy
50
+7
+16% +$2.03K ﹤0.01% 1895
2025
Q4
$12.7K Buy
43
+13
+43% +$3.92K ﹤0.01% 1885
2025
Q3
$7.39K Buy
+30
New +$6.05K ﹤0.01% 2051
2024
Q2
Sell
-457
Closed -$20.5K 2080
2024
Q1
$20.5K Buy
+457
New +$17.3K ﹤0.01% 1352

Other funds holding CLS

Geneos Wealth Management's CLS Position: Q1 2026 in Review

Geneos Wealth Management increased its Celestica (CLS) stake by 16% in Q1 2026, buying an estimated $2.03K and bringing the position to 50 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Geneos Wealth Management first reported a position in CLS in Q1 2024 and has held it in 4 quarters since. The position peaked at $20.5K in Q1 2024. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Geneos Wealth Management held 50 shares of Celestica worth $14.1K as of Q1 2026.
  • Geneos Wealth Management bought 7 Celestica shares in Q1 2026, an estimated $2.03K.
  • Celestica made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1895 holding.
  • Geneos Wealth Management first reported a position in Celestica in Q1 2024 and has held it in 4 quarters since.
  • Geneos Wealth Management's Celestica position peaked at $20.5K in Q1 2024.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.